Advertisements

https://www.businessinsider.com/young-blood-transfusions-open-accepting-paypal-payments-cities-ambrosia-2019-1

.To Jesse Karmazin, a startup founder and Stanford Medical School graduate, blood is the next big government-approved drug.

Roughly three years ago, Karmazin launched Ambrosia, a startup that fills the veins of older people with blood from younger donors, hoping the procedure would help conquer aging by rejuvenating the body’s organs. As Business Insider previously reported, there’s little to no evidence to suggest this would work.